Hotline:+86 2884841969
Outbound Sales&Marketing

Tel: +86 2884841969 
Mobile: +86 18716376478 (English) 
Skype/Wechat:+86 18716376478

Mr. Yang  
Tel: +86 2884871826
Mobile: +86 13908183771   
Enlai News Your current location: Homepage >Enlai News
First line treatment for chronic lymphocytic leukemia

As a first line treatment drugs for chronic lymphocytic leukemia, Ibrutinib improves survival compared with Ofatumumab in patients with previously treated Chronic Lymphocytic Leukemia.

Can you manufacture other peptides exclusively from your product list?2019-05-17

From Poverty to Harvard Postdoc2013-10-24

What are the acceptable payment methods?2019-05-05

Fingerprints Expose Chemical Identities 2019-01-04

2019 CPHI Shanghai Bio-Pharm Expo 2019-08-18